Valuation: biote Corp.

Market Cap 69.16M 60.57M 55.79M 51.78M 98.33M 6.6B 99.66M 668M 260M 3.24B 260M 254M 11.23B P/E 2026 *
10.7x
P/E 2027 * 7.77x
Enterprise Value 155M 136M 125M 116M 220M 14.79B 223M 1.5B 583M 7.26B 582M 569M 25.16B EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.69x
Free-Float
85.15%
Yield 2026 *
-
Yield 2027 * -
1 day+5.07%
1 week+36.53%
Current month+20.63%
1 month-2.56%
3 months+39.02%
6 months-10.24%
Current year-12.31%
1 week 1.87
Extreme 1.87
2.3
1 month 1.63
Extreme 1.63
2.5
Current year 1.27
Extreme 1.27
2.68
1 year 1.27
Extreme 1.27
4.75
3 years 1.27
Extreme 1.27
8.44
5 years 1.27
Extreme 1.27
10.52
10 years 1.27
Extreme 1.27
10.52
Manager TitleAgeSince
Chief Executive Officer 49 2026-06-11
Chief Tech/Sci/R&D Officer 69 2024-02-29
General Counsel 46 2021-05-31
Director TitleAgeSince
Director/Board Member 68 2022-04-30
Chairman 61 2022-04-30
Director/Board Member 67 2022-11-02
Date Insider Type Main position Quantity % Market Cap.
06-11Free

Chief Executive Officer

206,746 0.6816%
06-07Free

Chief Executive Officer

130,000 0.4286%
06-07Free

Chairman

114,157 0.3764%
Change 5-day change 1-year change 3-year change Capi.($)
+5.07%+36.53%-45.97%-63.87% 69.16M
+2.00%+9.65%-12.45%+32.85% 154M
-2.50%-11.29%-31.62%-88.63% 110M
0.00%+20.00%+11.11%+4.35% 59.06M
Average +1.34%+14.22%-19.73%-28.82% 98.08M
Weighted average by Cap. +1.29%+10.84%-20.20%-22.62%

Financials

2026 *2027 *
Net sales 191M 167M 154M 143M 271M 18.2B 275M 1.84B 717M 8.93B 717M 701M 30.98B 204M 178M 164M 152M 289M 19.42B 293M 1.97B 765M 9.53B 764M 748M 33.05B
Net income 7.74M 6.78M 6.24M 5.79M 11M 738M 11.15M 74.72M 29.08M 362M 29.06M 28.42M 1.26B 10.67M 9.35M 8.61M 7.99M 15.17M 1.02B 15.38M 103M 40.1M 500M 40.08M 39.2M 1.73B
Net Debt 85.86M 75.19M 69.26M 64.28M 122M 8.19B 124M 829M 323M 4.02B 322M 315M 13.94B 71.8M 62.89M 57.92M 53.76M 102M 6.85B 103M 693M 270M 3.36B 270M 264M 11.66B
Logo biote Corp.
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Employees
223
Date Price Change Volume
26-07-06 US$2.280 +5.07% 260,332
26-07-02 US$2.170 +9.05% 265,157
26-07-01 US$1.990 +5.29% 246,128
26-06-30 US$1.890 +13.17% 537,839
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.280USD
Average target price
2.986USD
Spread / Average Target
+30.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BTMD Stock